Thermo Fisher Q2 GAAP EPS $4.04 (+15%), Adj. EPS $5.37 (+4%), raises FY 2024 guidance

THERMO FISHER SCIENTIFIC INC.

2024-Q2 EPS reported $7.50 revenue$20,886,000,000

Revenue $10.54B, down 1% YoY; organic revenue -1%, core organic revenue flat.
GAAP operating margin improved to 17.3% from 14.8%; adjusted operating margin 22.3% vs 22.2%.
Completed Olink acquisition post-quarter to extend proteomics capabilities.
Raised FY 2024 revenue guidance to $42.4-43.3B (prev. $42.3-43.3B) and adj. EPS to $21.29-22.07 (prev. $21.14-22.02).
Launched multiple new instruments including Stellar mass spec and biobased bioprocessing film.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.